Bröker Michael, Bukovski Suzana, Culic Davor, Jacobsson Susanne, Koliou Maria, Kuusi Markku, Simões Maria João, Skoczynska Anna, Toropainen Maija, Taha Muhamed-Keir, Tzanakaki Georgina
Novartis Vaccines and Diagnostics GmbH; Marburg, Germany.
University Hospital for Infectious Diseases Dr. Fran Mihaljević; Zagreb, Croatia.
Hum Vaccin Immunother. 2014;10(6):1725-8. doi: 10.4161/hv.28206. Epub 2014 Mar 7.
Neisseria meningitidis is differentiated into 12 distinct serogroups, of which A, B, C, W, X, and Y are medically most important and represent an important health problem in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Recent epidemiological surveillance has indicated an increase of serogroup Y invasive meningococcal disease in some parts of Europe as shown in the epidemiological data for 2010 and 2011 from various European countries previously published in this journal. (1)(,) (2) Here, data from 33 European countries is reported indicating that the emergence of serogroup Y continued in 2012 in various regions of Europe, especially in Scandinavia, while in Eastern and South-Eastern Europe the importance of serogroup Y remained low.
脑膜炎奈瑟菌可分为12个不同的血清群，其中A、B、C、W、X和Y血清群在医学上最为重要，在世界不同地区均构成重要的健康问题。脑膜炎奈瑟菌的流行病学随时间和地域变化而难以预测。近期的流行病学监测表明，欧洲部分地区血清群Y侵袭性脑膜炎球菌病有所增加，如先前发表在本杂志上的来自多个欧洲国家的2010年和2011年流行病学数据所示。(1)(,) (2) 在此，报告了来自33个欧洲国家的数据，表明血清群Y在2012年在欧洲各地区持续出现，尤其是在斯堪的纳维亚半岛，而在东欧和东南欧，血清群Y的重要性仍然较低。
